Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02508428 · ClinicalTrials.gov registry record · NA

Marathon and Enduron Polyethylene at Long-Term Follow-up

A NA study of Osteoarthritis and Arthritis, sponsored by Anderson Orthopaedic Research Institute.

Completed
Registry status
NA
Development phase
230
Enrollment target
1
Study location

NCT02508428 is a NA study of Osteoarthritis and Arthritis that has completed, run by Anderson Orthopaedic Research Institute. The registered enrollment target is 230 participants, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02508428, a NA study of Osteoarthritis and Arthritis, has completed, sponsored by Anderson Orthopaedic Research Institute.

COMPLETED
Registry status
NA
Development phase
230 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine whether crosslinked Marathon and standard Enduron polyethylene liners show differences in survivorship due to wear-related revisions at minimum 14-year follow-up and every 5 years after.

Interventions

  • DEVICE Hip Replacement with crosslinked Marathon polyethylene
  • DEVICE Hip Replacement with noncrosslinked Enduron polyethylene

Study Locations (1)

Virginia

  • Anderson Orthopaedic Research Institute - Alexandria

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 1999-01-06
Est. Completion 2017-06-22
Phase NA

What the Registry Record Tells You About NCT02508428

The ClinicalTrials.gov registry entry for NCT02508428 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (72% lower). The listed sponsor is Anderson Orthopaedic Research Institute, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Hip Replacement with crosslinked Marathon polyethylene is the first listed.

NCT02508428 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT02508428 about?

NCT02508428 is a clinical study titled "Marathon and Enduron Polyethylene at Long-Term Follow-up". The purpose of the study is to determine whether crosslinked Marathon and standard Enduron polyethylene liners show differences in survivorship due to wear-related revisions at minimum 14-year follow-up and every 5 years after.

What is the current status of trial NCT02508428?

This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 1999-01-06. Estimated completion is 2017-06-22.

What conditions does trial NCT02508428 study?

This clinical trial studies the following conditions: Osteoarthritis, Arthritis, Musculoskeletal Diseases, Rheumatic Diseases, Joint Diseases.

What interventions are being tested in trial NCT02508428?

The interventions under investigation include: Hip Replacement with crosslinked Marathon polyethylene (DEVICE), Hip Replacement with noncrosslinked Enduron polyethylene (DEVICE).

Who is sponsoring clinical trial NCT02508428?

This trial is sponsored by Anderson Orthopaedic Research Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02508428 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.